India to Uzbekistan: Dexamethasone Export Trade Route

The India to Uzbekistan Dexamethasone corridor is one of India's established pharmaceutical export routes, with 66 shipments documented worth a combined $1.6M USD. The route is dominated by AGIO PHARMACEUTICALS LIMITED, which alone accounts for roughly 32% of all export value, reflecting the consolidated nature of India's dexamethasone manufacturing sector.

Across 13 active suppliers, the average shipment value stands at $24.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with dexamethasone's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 20.0%, placing it at rank #9 among India's top dexamethasone export destinations globally.

On the import side, key buyers of Indian dexamethasone in Uzbekistan include AGIO HEALTHCARE INTERNATIONAL LLC, AMRITA PHARMA LLC , OOO "FUTURE WORLD GROUP" and 18 others. AGIO HEALTHCARE INTERNATIONAL LLC is the single largest importer with 22 shipments valued at $477.3K USD.

India's dexamethasone exports to Uzbekistan are driven primarily by a handful of large-scale manufacturers. AGIO PHARMACEUTICALS LIMITED with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in Uzbekistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AGIO PHARMACEUTICALS LIMITED, AGIO PHARMACEUTICALS LIMITED , HARASHA PHARMA PRIVATE LIMITED — together account for 66% of total trade value on this route. The average shipment value of $24.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as dexamethasone - agio solution for injection 4mg/ml (dexamethasone sodium phosphate injection bp) and dexamethasone agio solution for injectio , suggesting that buyers in Uzbekistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AGIO HEALTHCARE INTERNATIONAL LLC is the largest importer with 22 shipments worth $477.3K USD — representing 30% of all dexamethasone imports from India on this route. A total of 21 buyers are active on this corridor.